Table 2 Level of NT-pro-BNP (pg/mL) according to the underlying disease or clinical situation
Variables | No. (%) | Median (IQR) | p-value |
|---|---|---|---|
Female | 534 (37.1%) | 420 (137–1,780) | 0.008 |
Male | 906 (62.9%) | 292 (84–1,520) | |
Cirrhosis (-) | 1,283 (89.1%) | 385 (109–1,808) | <0.001 |
Cirrhosis (+) | 157 (10.9%) | 187 (83–526) | |
Hypertension (-) | 896 (62.2%) | 276 (86–1,208) | <0.001 |
Hypertension (+) | 544 (37.8%) | 456 (125–2,384) | |
IHD (-) | 1,280 (88.9%) | 296 (93–1,309) | <0.001 |
IHD (+) | 160 (11.1%) | 967 (251–4,894) | |
CHF (-) | 1,332 (92.5%) | 299 (93–1,382) | <0.001 |
CHF (+) | 108 (7.5%) | 1,226 (413–8,346) | |
DM (-) | 1,077 (74.8%) | 284 (94–1,223) | <0.001 |
DM (+) | 363 (25.2%) | 611 (129–3,373) | |
CRF (-) | 1,296 (90.0%) | 276 (91–1,127) | <0.001 |
CRF (+) | 144 (10.0%) | 2,799 (773–16,768) | |
Cancer (-) | 896 (62.2%) | 390 (101–2,214) | 0.027 |
Cancer (+) | 544 (37.8%) | 285 (108–1,024) | |
Severe sepsis or septic shock (-) | 1,131 (78.5%) | 269 (85–1,112) | <0.001 |
Severe sepsis or septic shock (+) | 309 (21.5%) | 890 (206–7,946) | |
ALI or ARDS (-) | 1,317 (91.5%) | 309 (100–1,389) | <0.001 |
ALI or ARDS (+) | 123 (8.5%) | 827 (191–3,504) | |
Elective surgery | 502 (34.9%) | 195 (78–492) | <0.001 |
Emergency surgery | 103 (7.2%) | 233 (97–981) | |
Surgery (-) | 835 (58.0%) | 604 (148–3,170) | |
MV (-) | 770 (53.5%) | 264 (83–1,064) | <0.001 |
MV (+) | 670 (46.5%) | 456 (129–2,542) | |
Vasoactive drug (-) | 904 (62.8%) | 237 (79–828) | <0.001 |
Vasoactive drug (+) | 536 (37.2%) | 721 (178–3,720) | |
RRT (-) | 1,268 (88.1%) | 278 (93 – 1,164) | <0.001 |
RRT (+) | 172 (11.9%) | 2,377 (413–18,751) |